title: A 2020 vision for vaccines against HIV, tuberculosis and malaria.
abstract: Acquired immune deficiency syndrome (AIDS), malaria and tuberculosis collectively cause more than five million deaths per year, but have nonetheless eluded conventional vaccine development; for this reason they represent one of the major global public health challenges as we enter the second decade of the twenty-first century. Recent trials have provided evidence that it is possible to develop vaccines that can prevent infection by human immunodeficiency virus (HIV) and malaria. Furthermore, advances in vaccinology, including novel adjuvants, prime-boost regimes and strategies for intracellular antigen presentation, have led to progress in developing a vaccine against tuberculosis. Here we discuss these advances and suggest that new tools such as systems biology and structure-based antigen design will lead to a deeper understanding of mechanisms of protection which, in turn, will lead to rational vaccine development. We also argue that new and innovative approaches to clinical trials will accelerate the availability of these vaccines.
authors: Novartis Vaccines and Diagnostics, 53100 Siena, Italy. rino.rappuoli@novartis.com
authors: Rino
authors: R
authors: Rappuoli
authors: Alan
authors: A
authors: Aderem
references: Nat Rev Immunol. 2011 Jan;11(1):57-64
references: 21179119
references: Nat Rev Microbiol. 2006 Jun;4(6):469-76
references: 16710326
references: Nature. 2010 Aug 19;466(7309):973-7
references: 20725040
references: Lancet. 2010 Jun 12;375(9731):2110-9
references: 20488515
references: Science. 1999 May 28;284(5419):1520-3
references: 10348738
references: Lancet Infect Dis. 2011 Feb;11(2):102-9
references: 21237715
references: Hum Vaccin. 2010 Jan;6(1):97-106
references: 19946222
references: Lancet. 2007 Nov 3;370(9598):1543-51
references: 17949807
references: Immunity. 2010 Oct 29;33(4):555-66
references: 21029965
references: Sci Transl Med. 2010 Oct 13;2(53):53ra74
references: 20944089
references: J Infect Dis. 2006 Dec 15;194(12):1661-71
references: 17109337
references: Lancet. 2004 Oct 16-22;364(9443):1411-20
references: 15488216
references: N Z Med J. 2009 Mar 13;122(1291):48-59
references: 19322255
references: J Exp Med. 2008 Dec 22;205(13):3119-31
references: 19047440
references: Sci Transl Med. 2011 Jul 13;3(91):91ra62
references: 21753121
references: Immunity. 2010 Oct 29;33(4):567-77
references: 21029966
references: Immunity. 2010 Oct 29;33(4):516-29
references: 21029962
references: Nature. 1967 Oct 14;216(5111):160-2
references: 6057225
references: Immunol Rev. 2004 Oct;201:268-90
references: 15361247
references: J Infect Dis. 1995 Jun;171(6):1576-85
references: 7769295
references: Nat Immunol. 2009 Jan;10(1):116-125
references: 19029902
references: Nat Rev Immunol. 2011 Jan;11(1):65-70
references: 21164527
references: N Engl J Med. 1997 Jan 9;336(2):86-91
references: 8988885
references: Proc Natl Acad Sci U S A. 2007 Jul 24;104(30):12488-93
references: 17636123
references: Clin Cancer Res. 2005 Nov 1;11(21):7872-8
references: 16278411
references: Science. 2004 Jan 16;303(5656):316
references: 14726576
references: N Engl J Med. 2009 Dec 3;361(23):2209-20
references: 19843557
references: N Engl J Med. 2008 Dec 11;359(24):2521-32
references: 19064627
references: J Infect Dis. 2005 Mar 1;191(5):654-65
references: 15688278
references: Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3877-82
references: 19237568
references: Science. 2010 Aug 27;329(5995):1060-4
references: 20647428
references: Vaccine. 2009 Jun 24;27 Suppl 2:B20-9
references: 19477053
references: Expert Rev Vaccines. 2007 Oct;6(5):723-39
references: 17931153
references: J Infect Dis. 2011 Mar 15;203(6):765-72
references: 21343146
references: J Infect Dis. 2002 Apr 15;185(8):1155-64
references: 11930326
references: Trends Biotechnol. 2008 Dec;26(12):659-67
references: 18977045
references: Lancet. 2008 Nov 29;372(9653):1881-1893
references: 19012954
references: Nat Immunol. 2008 Jul;9(7):725-32
references: 18563083
references: Infect Immun. 2008 Jun;76(6):2660-70
references: 18378635
references: Genes Immun. 2011 Jan;12(1):15-22
references: 20861863
references: J Virol. 2011 Jan;85(2):1099-116
references: 21068249
references: Sci Transl Med. 2011 Apr 20;3(79):79ps13
references: 21508308
references: Annu Rev Immunol. 2010;28:413-44
references: 20192810
references: Immunity. 2010 Oct 29;33(4):542-54
references: 21029964
references: N Engl J Med. 2007 May 17;356(20):2073-81
references: 17507706
references: Nature. 2002 Feb 7;415(6872):694-701
references: 11832958
references: Nat Med. 2011 Feb;17(2):189-94
references: 21258338
references: PLoS One. 2009 Dec 01;4(12):e8110
references: 19956619
references: Science. 2010 Aug 13;329(5993):856-61
references: 20616233